Completion of selection and description of regulatory acceptable “contexts of use” for advanced animal vs human-on-chip model developments

Completion of selection and description of regulatory acceptable “contexts of use” for advanced animal vs human/patient-on-a-chip model developments with fit to preclinical developments and pivotal clinical trials of WP 3